4//SEC Filing
Patterson Joshua F. 4
Accession 0001209191-20-054618
CIK 0001662524other
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 4:02 PM ET
Size
9.9 KB
Accession
0001209191-20-054618
Insider Transaction Report
Form 4
Patterson Joshua F.
General Counsel
Transactions
- Disposition from Tender
Common Stock
2020-10-12$18.15/sh−26,532$481,556→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$1.16/sh−13,750$15,950→ 0 totalExercise: $16.99Exp: 2030-01-01→ Common Stock (13,750 underlying) - Disposition to Issuer
Stock Option (right to buy)
2020-10-12$5.39/sh−7,500$40,425→ 0 totalExercise: $12.76Exp: 2030-03-18→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]This option, which provided that 1/4th of the shares would vest one year after January 2, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $15,950.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
- [F2]This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $40,425.00, representing the difference between the exercise price of the option and the acquisition price of $18.15.
Documents
Issuer
AKCEA THERAPEUTICS, INC.
CIK 0001662524
Entity typeother
Related Parties
1- filerCIK 0001805702
Filing Metadata
- Form type
- 4
- Filed
- Oct 12, 8:00 PM ET
- Accepted
- Oct 13, 4:02 PM ET
- Size
- 9.9 KB